2m 2m 2m 2m 2m 2m 2m
AARDVARK THERA (AARD)
NASDAQ
$6.89+$0.29 (+4.39%)
Price as of Aug 03, 2026 11:32 AM EDT- $144.4MMarket Cap
- -45.59%1-Year Change
- BiotechnologyIndustry
AARDVARK THERA (AARD)
$6.89+$0.29 (+4.39%)
AARD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.60 | ||
Change | +$0.20 (+3.12%) | ||
Open | $6.31 | ||
High | $6.66 | ||
Low | $5.62 | ||
Previous Close | $6.40 | ||
Volume | 89,273 | ||
30-Day Average Volume | 390,851 | ||
1-Week Change | 4.43% | ||
1-Month Change | 14.58% | ||
1-Year Change | -45.59% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.9M | ||
Total Assets | $98.6M | ||
Market Cap | $144.4M | ||
Enterprise Value | $82.0M | ||
Period: QTR TTM FY | |||
Revenue | -$13,000.00 | ||
Net Income | -$21.6M | ||
Free Cash Flow | -$18.9M | ||
EBIT | -$21.6M | ||
EBITDA | -$21.6M | ||
Net Working Capital | $82.0M | ||
EPS | -$0.99 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | -6,308 | ||
P/B | 2 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 07/21/2008 | ||
Earnings & Revenue